Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Apr;29(2):349-351.
doi: 10.3350/cmh.2023.0082. Epub 2023 Mar 20.

Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap

Shen-Yung Wang  1
Affiliations
Editorial

Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap

Shen-Yung Wang. Clin Mol Hepatol. 2023 Apr.
No abstract available

Keywords: Hepatocellular carcinoma; Surveillance; Systemic therapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The author has no conflicts to disclose.

Comment on

References

    1. Shao YY, Wang SY, Lin SM, Diagnosis Group. Systemic Therapy Group Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. J Formos Med Assoc. 2021;120:1051–1060. - PubMed
    1. Su TH, Wu CH, Liu TH, Ho CM, Liu CJ. Clinical practice guidelines and real-life practice for hepatocellular carcinoma in Taiwan. Clin Mol Hepatol. 2023;29:230–241. - PMC - PubMed
    1. Sohn W, Kang D, Kang M, Guallar E, Cho J, Paik YH. Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease. Clin Mol Hepatol. 2022;28:851–863. - PMC - PubMed
    1. Kim BH, Cho Y, Park JW. Surveillance for hepatocellular carcinoma: It is time to move forward. Clin Mol Hepatol. 2022;28:810–813. - PMC - PubMed
    1. Yu JH, Cho SG, Jin YJ, Lee JW. The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection. Clin Mol Hepatol. 2022;28:351–361. - PMC - PubMed

MeSH terms